Membership hub Contact Us

NPA responds to Mounjaro pharmacy rebate scheme 

28th August 2025


This rebate will mitigate some of the impact of the increase in Mounjaro prices faced by pharmacies but patients should still anticipate seeing a rise in prices from 1st September.

Greenlight pharmacy 2024 (29).jpg

Olivier Picard, Chair of the National Pharmacy Association said: 

“Pricing is a matter for the manufacturers and pharmacies will do all they can to support patients when prices change.

"This rebate will mitigate some of the impact of the increase in Mounjaro prices faced by pharmacies but patients should still anticipate seeing a rise in prices from 1st September.

"Prices advertised in many pharmacies will already reflect this discount and pharmacies will also have to wait to receive this retrospectively after dispensing.

"Pharmacies will access price rebates if they can as a way of keeping prices accessible.

"Pharmacies are working hard to support their patients and explore if there are options to minimise disruption to their treatment programme."

Share this article

Date published: 28th August 2025

National Pharmacy Association Ltd (Company No. 1281757) is registered in England and Wales and authorised and regulated by the Financial Conduct Authority. NPA Insurance Ltd (Company No. 64269) is registered in England and Wales. Authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority. Registered office: Mallinson House, 40–42 St Peters Street, St Albans, AL1 3NP. NPA Copyright © 2026. All Rights Reserved.

©2026